Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Target Corporation heads into its November earnings window with a stock that has lost momentum fast, down 8.2% over the past month and 3.7% over the past week to close at $150.92, while short sellers have been quietly rebuilding positions in the background.
The positioning picture is less dramatic than the price action suggests. Short interest has climbed 25.5% over the past month to 3.8% of the free float, a meaningful build in percentage terms but still a modest absolute level for a large-cap retailer. The move from roughly 13.6 million shares short in early September to 17.1 million now is real, but borrowing costs remain almost trivially low at 0.40%, and borrow availability is extremely loose at over 2,600% of short interest, meaning there is no squeeze pressure and no friction for new shorts to enter. Options traders are not adding much conviction either way: the put/call ratio at 0.94 is barely below its 20-day average of 0.96, and the z-score of -0.47 puts the reading within normal range. The ORTEX short score of 38.6 has crept higher over the past two weeks but remains well below levels that would flag aggressive short-side positioning. Collectively, the lending market and options market describe a stock that is drifting lower rather than being actively hunted by bears.
The Street is more divided than the consensus "hold" rating implies. Eleven analysts carry buy ratings against twenty-one holds, and the mean price target of $164.68 sits about 9% above the current price, a gap that has compressed as the stock has sold off from higher levels this summer. The most notable recent action came from HSBC, which on September 30 upgraded Target to Buy from Hold and lifted its target to $190. That move stands out given the stock has since fallen further. Goldman Sachs and Citigroup both maintain Neutral ratings with targets in the $160 to $161 range, closely bracketing the current price. Barclays remains the outlier bear with an Underweight and a $140 target. The bull case centres on the turnaround narrative: comparable sales up 3.8% on 3.6% traffic growth, management raising full-year net sales guidance toward 5% growth and lifting EPS guidance to a $9.90 to $10.90 range, with Food, Beauty, and private-label brands all outperforming. Bears point to the roughly 80% of revenue tied to discretionary and semi-discretionary categories, tariff and labour cost headwinds, and the intensifying competition from Amazon and hard discounters. Valuation multiples have compressed with the stock: the P/E has dropped by about 1.1 turns over the past month to 15.5x, and EV/EBITDA has eased to 8.9x. The 90-day EPS momentum factor ranks in the 80th percentile, suggesting estimate revisions have been running positive, though the analyst recommendation score is at a perfect 100th percentile, which simply reflects how few outright sell ratings exist rather than widespread conviction.
Insider activity deserves attention, even if the framing matters. CEO Brian Cornell sold 50,000 shares at an average of $163.56 on August 25, generating $8.2 million in proceeds, with no 10b5-1 plan on record. That was a discretionary open-market sale at prices well above where the stock trades now. CFO Melissa Kremer sold 15,500 shares at $169.96 the day before, also without a plan designation, netting $2.6 million. Both executives were selling near what turned out to be the summer peak. The 90-day insider net across all transaction types is negative $11.0 million. More recent activity has been compensation-related grants and tax-withholding transactions rather than open-market conviction trades, but the directional signal from the two largest moves is clear: senior management was distributing at elevated prices.
Retail attention has also faded. Wikipedia page views for Target rank 1.2 standard deviations below their own 90-day average as of early October, a low reading that points to declining retail investor engagement rather than a catalyst-driven moment. Peers are holding up better this week: DG added 2.1% over the week and DLTR gained 2.0%, while GO surged 6.1%. Target's 3.7% weekly decline against a backdrop of modest gains in the discount and grocery retail group suggests company-specific pressure rather than sector-wide selling.
The next scheduled earnings date is November 17. With short interest building but the borrow market still loose, and with insiders having sold at prices roughly 10% above current levels, the key question heading into that date is whether the turnaround metrics that drove the summer rally, specifically traffic growth and comp-sales momentum, can hold through a period of slowing consumer spending and rising cost pressure.
See the live data behind this article on ORTEX.
Open TGT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
